about
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.Long non-coding RNA HOTAIR in carcinogenesis and metastasisZEB1: at the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistanceThe emerging molecular machinery and therapeutic targets of metastasismiR-100 induces epithelial-mesenchymal transition but suppresses tumorigenesis, migration and invasionTumour invasion and metastasis initiated by microRNA-10b in breast cancerPhosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesisTherapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model.FoxO transcription factors promote AKT Ser473 phosphorylation and renal tumor growth in response to pharmacologic inhibition of the PI3K-AKT pathwayα-catenin. A tumor suppressor beyond adherens junctions.ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1.Determinants of breast cancer progression.miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13.LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic markerNon-coding RNAs as regulators of mammary development and breast cancer.MicroRNAs in malignant progression.BAF180 regulates cellular senescence and hematopoietic stem cell homeostasis through p21Micromanagers of malignancy: role of microRNAs in regulating metastasis.Profiling of Cross-Functional Peptidases Regulated Circulating Peptides in BRCA1 Mutant Breast Cancer.α-catenin acts as a tumour suppressor in E-cadherin-negative basal-like breast cancer by inhibiting NF-κB signalling.Deubiquitylation and stabilization of PTEN by USP13MicroRNA control of epithelial-mesenchymal transition and metastasis.MicroRNA and Metastasis.The role of deubiquitinases in breast cancer.TRIP12 as a mediator of human papillomavirus/p16-related radiation enhancement effects.Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways.Polycystin-1 regulates extracellular signal-regulated kinase-dependent phosphorylation of tuberin to control cell size through mTOR and its downstream effectors S6K and 4EBP1.USP51 promotes deubiquitination and stabilization of ZEB1.The Future of Radiobiology.MicroRNAs and metastasis: small RNAs play big roles.Regulation of PI3K signaling in T-cell acute lymphoblastic leukemia: a novel PTEN/Ikaros/miR-26b mechanism reveals a critical targetable role for PIK3CD.ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast Cancer.Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types.SKP2- and OTUD1-regulated non-proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity.Ubiquitin-specific peptidase 2a (USP2a) deubiquitinates and stabilizes β-cateninLong noncoding RNA MALAT1 suppresses breast cancer metastasisThe AKT-mTOR pathway plays a critical role in the development of leiomyosarcomasNew Insights into Long Non-Coding RNA in Cancer and MetastasisEnergy-stress-mediated AMPK activation inhibits ferroptosispiRNA-unbound PIWIL1 promotes metastasis
P50
Q24613599-6C8348D6-F706-47B7-99BC-E40F7CFEA205Q27004009-5048CEB5-399B-4B1A-97C2-3D4FD518BD58Q27015111-D7713E63-9560-4088-88FC-101772052047Q27022207-055845E2-4202-4C6D-9C64-988678535BD4Q27316744-525D936A-C1A9-4A8F-B08C-5D5299CFB9D2Q28131829-714C1706-D14E-44DE-A859-A90BB7495810Q28246808-A3F5E81A-49A1-4BB1-BFA0-5207A8119690Q33780722-7EF38ED8-21C8-486B-AF74-EEC7375F6E15Q33864477-B1254C92-7C7E-4B76-8FAE-733E906B0DECQ34028517-AF945539-AE5F-4B3B-9AF4-8562F7856A12Q34115685-F27D835D-6B4B-4DB4-A23C-D9EC5F83FA44Q34147781-471D262F-A0F9-4CAC-8A49-8F2BDC4A5BF5Q35225778-D730B8A6-3330-4C87-A634-82129741F9DFQ36934375-73C21119-F54F-41A8-B0E0-AE9451AB56CCQ36940253-97438F0A-7AB7-44AE-B753-0BD40CB24165Q37078788-6FF63A83-145A-4296-94CB-ED7BC22D63CFQ37190016-420F9F62-67FC-432E-BBD4-FFB2E7CF24A7Q37233362-898D50AF-02D8-49B8-8912-DAFF6D66F62DQ37443351-BB133BB9-800E-4A36-BF93-F0733423E287Q37619596-62366B16-086D-45F5-BAAF-287A7794E6DFQ37633952-6A834FD5-793D-4B73-9D4F-2DEDE58C38D7Q38017596-EA9674B4-B4EF-4CDC-896C-C26BD321F6A3Q38950559-94450AC3-DC85-4D3B-A36E-D18DC90ED400Q39008850-BAA21740-9E46-48B1-BC06-148A8935BDD1Q39593598-E2634B04-B799-4631-8710-8FE426516F6EQ40498643-BAC2C81C-9D9C-4E65-A131-5C0FB72E686AQ42015539-B980B815-4601-48C5-83F6-999F7C07E123Q43525541-619B4EF3-90FB-4D5A-841F-FC32E82D67F0Q46136392-F31BC734-C3A9-4507-9008-CFD51A388EBDQ49874020-A945FBA3-F3C4-49E5-85B6-2E942F861CC1Q51103234-E9124F86-E13D-4B1D-9FF7-FFBCCE5BF957Q52718548-DB2205D6-5379-4954-978E-02896A6B156AQ52721693-AF005559-F85B-4B83-BB66-5ACF4F3A8850Q55282550-42DF3BF4-0A62-47E3-9145-348B86699BDAQ57494119-0E59879A-DCEA-40FB-9361-CE5ACF9C6C09Q57804807-410F5748-9308-4007-91FB-1E6E77188623Q60021742-DD3B06E0-E698-4C95-BA48-C03627637AD7Q64244607-B101A1AD-4BBC-4148-A5E3-329D3073A710Q89583682-CD05720F-93B8-44C2-9A9F-39652E1179B2Q90591305-9D3CF39C-537E-46AF-A993-6EB702913502
P50
description
researcher ORCID: 0000-0001-9965-989X
@en
name
Li Ma
@ast
Li Ma
@en
Li Ma
@nl
Li Ma
@sl
type
label
Li Ma
@ast
Li Ma
@en
Li Ma
@nl
Li Ma
@sl
prefLabel
Li Ma
@ast
Li Ma
@en
Li Ma
@nl
Li Ma
@sl
P106
P31
P496
0000-0001-9965-989X